From StructYou came from “Illumina’s earnings look healthier, but sales barely budged, and the market is paying 37.6x for the rebound”Back to the brief ↗Feed / ILMN

Illumina, Inc.

ILMN

Healthcare · 205.10 -0.1% today

Follow ILMNAlerts

Jodie read · what matters now

Operating margin swung to +18.6% while revenue fell 0.7%; the stock trades at a 37.6x P/E on a $32.0B market cap.

The story is only the start. Jodie keeps watching the filing evidence, the companies connected to ILMN, and whether its market group begins moving.

P/E37.6xlatest annual facts
Revenue YoY-0.7%2025-12-28
Operating margin18.6%+37.6 pts YoY
Latest story10-K · Feb 12, 2026Read on Struct ↗
Disclosed connections22 verified links20 additional receipts in Pro
Organic co-movement groupDiagnostics & Research · FollowerLast observed group; it is between live snapshots · See active groups →

Who this business touches

The relationships behind ILMN

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

LABFiling-linked nameinvesteeFull receipt with Pro →

Depended on by

CDNACareDx, Inc.supplierFull receipt with Pro →

Filing peers

No filing peers are available for this name yet.

You can see the shape of the network here. Pro opens 20 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →

What is moving around it

Live connections

ILMN is currently a Follower in the organic co-movement group Diagnostics & Research. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for ILMN; it is not active in the latest market snapshot.

Theme membership history

No durable theme membership has been observed for this name yet.